Filing Details
- Accession Number:
- 0001415889-23-002954
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-21 19:00:58
- Reporting Period:
- 2023-02-16
- Accepted Time:
- 2023-02-21 19:00:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1159036 | Halozyme Therapeutics Inc. | HALO | Biological Products, (No Disgnostic Substances) (2836) | 880488686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1910662 | Nicole Labrosse | C/O Halozyme Therapeutics, Inc. 12390 El Camino Real San Diego CA 92130 | Svp, Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-16 | 5,094 | $0.00 | 11,591 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-16 | 2,525 | $49.26 | 9,066 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2023-02-16 | 5,094 | $0.00 | 5,094 | $0.00 |
| Common Stock | Option to Purchase Common Stock | Acquisiton | 2023-02-16 | 61,061 | $0.00 | 61,061 | $49.26 |
| Common Stock | Restricted Stock Units | Acquisiton | 2023-02-16 | 21,316 | $0.00 | 21,316 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,279 | No | 4 | M | Direct | ||
| 61,061 | 2024-02-16 | 2033-02-16 | No | 4 | A | Direct |
| 21,316 | 2024-02-16 | No | 4 | A | Direct |
Footnotes
- The reported disposition of 2,525 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
- This option vests one-fourth on such date and then 1/48th monthly thereafter.
- This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.
Billionaire Hedge Funds
